Controversies in the management of low-risk differentiated thyroid cancer

MR Haymart, NH Esfandiari, MT Stang… - Endocrine …, 2017 - academic.oup.com
Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

[HTML][HTML] Controversies in the Management of Low-Risk Differentiated Thyroid Cancer

MR Haymart, NH Esfandiari, MT Stang… - Endocrine …, 2017 - ncbi.nlm.nih.gov
Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Controversies in the Management of Low-Risk Differentiated Thyroid Cancer

MR Haymart, NH Esfandiari, MT Stang, JA Sosa - Endocrine Reviews - academic.oup.com
Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management including surgery, use of radioactive iodine …

Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

MR Haymart, NH Esfandiari, MT Stang… - Endocrine …, 2017 - europepmc.org
Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Controversies in the Management of Low-Risk Differentiated Thyroid Cancer

MR Haymart, NH Esfandiari, MT Stang… - Endocrine …, 2017 - pubmed.ncbi.nlm.nih.gov
Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

MR Haymart, NH Esfandiari, MT Stang… - Endocrine …, 2017 - europepmc.org
Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …